41402-58-8

Usage

Uses

Used in Pharmaceutical Industry:
N-(3-aminophenyl)-2,2-dimethylpropanamide is used as a building block or intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be a versatile component in the development of new drugs.
Used in Organic Synthesis:
In the field of organic synthesis, N-(3-aminophenyl)-2,2-dimethylpropanamide is used as a reagent or precursor for the preparation of other organic compounds. Its ability to form various chemical bonds makes it a valuable asset in creating complex molecules.
Used in Material Science:
N-(3-aminophenyl)-2,2-dimethylpropanamide may also be utilized in material science for the development of new materials. Its structural properties could contribute to the creation of innovative materials with unique characteristics.
Used in Research Applications:
In research settings, N-(3-aminophenyl)-2,2-dimethylpropanamide serves as a subject of study for understanding its properties, reactivity, and potential uses. This can lead to the discovery of new applications and advancements in related fields.

Upstream product

• 108-45-2 m-phenylenediamine 
• 1538-75-6 2,2-dimethylpropanoic anhydride 
• 32597-30-1 N-(3-nitrophenyl)pivalamide 
• 3282-30-2 pivaloyl chloride 
• 99-09-2 3-nitro-aniline 

Downstream Products

• 25228-09-5 2,2-Dimethyl-N-[3-(3-propyl-ureido)-phenyl]-propionamide 
• 25228-58-4 N-[3-(2,2-Dimethyl-propionylamino)-phenyl]-butyramide 
• 25228-67-5 3-Methyl-but-2-enoic acid [3-(2,2-dimethyl-propionylamino)-phenyl]-amide 
• 25228-77-7 N-[3-(2,2-Dimethyl-propionylamino)-phenyl]-2-methyl-butyramide 
• 59517-46-3 But-3-enoic acid [3-(2,2-dimethyl-propionylamino)-phenyl]-amide 
• 25218-58-0 N-[3-(2-Methoxy-acetylamino)-phenyl]-2,2-dimethyl-propionamide 
• 25228-68-6 4-Methyl-pentanoic acid [3-(2,2-dimethyl-propionylamino)-phenyl]-amide 
• 59517-35-0 3-Chloro-N-[3-(2,2-dimethyl-propionylamino)-phenyl]-2,2-dimethyl-propionamide 
• 59517-56-5 N-[3-(2,2-Dimethyl-propionylamino)-phenyl]-2-ethyl-2-methyl-butyramide 
• 25228-48-2 2,2-Dimethyl-pentanoic acid [3-(2,2-dimethyl-propionylamino)-phenyl]-amide 
• 52304-31-1 N-[3-(3-Cyclopentyl-propionylamino)-phenyl]-2,2-dimethyl-propionamide 
• 59517-94-1 N-[3-(2,2-Dimethyl-propionylamino)-phenyl]-4-fluoro-benzamide 
• 59517-85-0 3-Chloro-N-[3-(2,2-dimethyl-propionylamino)-phenyl]-benzamide 
• 59517-84-9 2-Chloro-N-[3-(2,2-dimethyl-propionylamino)-phenyl]-benzamide 

Relevant academic research and scientific papers

MODULATORS OF TMEM16A FOR TREATING RESPIRATORY DISEASE

Compounds of general formula (I), which are useful for treating respiratory disease and other diseases and conditions modulated by TMEM16A. wherein A is defined as Formula.

BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Disclosed herein are compounds that are inhibitors of BDR4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BDR4 are also disclosed. In certain aspects, disclosed are compounds of Formula I through IV.

POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.

Copper-catalyzed synthesis of benzoxazoles via a regioselective C-H functionalization/C-O bond formation under an air atmosphere

(Chemical Equation Presented) An efficient method for the synthesis of functionalized benzoxazoles is described that involves a copper(II)-catalyzed regioselective C-H functionalization/C-O bond formation protocol. The use of dichlorobenzene as a solvent at 160°C allows the use of air as the terminal oxidant in the catalytic synthesis of benzoxazoles in a process that has high functional group tolerance. The presence of a directing group at the meta position markedly improves the reaction efficacy and a variety of 7-substituted benzoxazoles are selectively produced under mild reaction conditions. The mechanism of the reaction is also discussed in this report.

Metasubstituted thiazolidinones, their manufacture and use as a drug

This invention involves thiazolidinone of general formula (I) and its creation and use as inhibitors of polo like kinase (PLK) for the treatment of various diseases.

Thiazolidinones, their production and use as pharmaceutical agents

Thiazolidinones of general formula I in which Q, A, B, X, R1 and R2 have the meanings that are indicated in the description, as well as those of general formula IA in which Q, A, B, X, R1 and R2a have the meanings that are indicated in the description, their production and use as inhibitors of the polo-like kinase (PLK) for treating various diseases as well as intermediate products for the production of thiazolidinones are described.

Meta-bifunctional benzenes and herbicidal compositions

Meta-bifunctional of the general formula EQU1 wherein A is selected from the groups EQU2 These compounds possess herbicidal activity.